The next-generation sequencing (NGS; Ion AmpliSeq Colon and Lung Cancer Research Panel v2) of the tumour DNA revealed a classical epidermal growth factor receptor (EGFR) mutation in exon 21 (p.L858R; c.2573T > G). Here, EGFR is linked to neoplasm.